Clinical Trials Logo

Saline Solution, Hypertonic clinical trials

View clinical trials related to Saline Solution, Hypertonic.

Filter by:
  • None
  • Page 1

NCT ID: NCT03330704 Withdrawn - Cerebral Edema Clinical Trials

Small-Volume, Patient-Specific, Balanced Hypertonic Fluid Protocol Validation

Start date: November 28, 2017
Phase: Early Phase 1
Study type: Interventional

Many patients with traumatic brain injuries (including strokes, blood clots, or other brain injuries) are given concentrated salt water solutions (hypertonic saline) in order to treat brain swelling (cerebral edema). Current therapies consist of a mixture of sodium and chloride, which can lead to high levels of serum chloride and increased total body water. High levels of chloride can cause acidosis, which can cause the body to function sub-optimally. Therefore, the investigators are proposing to use two concentrated solutions in these patients at the same time that will allow for a lower total volume of solution administration and reduce the rise in chloride to prevent acidosis. The main outcome will therefore be the patients sodium level, chloride level and serum pH.

NCT ID: NCT01247064 Completed - Clinical trials for Bronchiolitis, Viral

Hypertonic Saline for Acute Bronchiolitis

Start date: October 2010
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether nebulized 3% hypertonic saline (HS) improves respiratory distress in children 2-23 months presenting to the emergency department (ED) with acute bronchiolitis with persistent respiratory distress after initial therapy with a trial of nebulized albuterol.